PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice

The increased PD-L1 expression induces poorer prognosis in melanoma. The small molecule inhibitors of PD-1/PD-L1 pathways have been an encouraging drug development strategy because of good affinity and oral bioavailability without immunogenicity and immunotoxicities of PD-1/PD-L1 antibodies. In this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Hu, Zhengping, Yu, Pengfei, Du, Guangying, Wang, Wenyan, Zhu, Haibo, Li, Ning, Zhao, Huijuan, Dong, Zhaoju, Ye, Liang, Tian, Jingwei
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7098565/
https://ncbi.nlm.nih.gov/pubmed/32214351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0228339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados